We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOOM icon
3726
DMC Global
BOOM
$155M
$21K ﹤0.01%
1,154
+747
+184% +$18.3K
BRBS icon
3727
Blue Ridge Bankshares
BRBS
$339M
$21K ﹤0.01%
1,314
+427
+48% +$6.32K
CCBG icon
3728
Capital City Bank Group
CCBG
$896M
$21K ﹤0.01%
739
-108
-13% -$2.84K
CCCC icon
3729
C4 Therapeutics
CCCC
$480M
$21K ﹤0.01%
2,832
-8,204
-74% -$72.2K
CCO icon
3730
Clear Channel Outdoor Holdings
CCO
$1.23B
$21K ﹤0.01%
19,780
+12,954
+190% +$27.1K
CNRG icon
3731
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$207M
$21K ﹤0.01%
265
-433
-62% -$35.1K
COMP icon
3732
Compass
COMP
$10.2B
$21K ﹤0.01%
5,950
+5,108
+607% +$27.9K
CTMX icon
3733
CytomX Therapeutics
CTMX
$760M
$21K ﹤0.01%
11,436
-13,319
-54% -$25.5K
FLIC
3734
DELISTED
First of Long Island Corp
FLIC
$21K ﹤0.01%
1,221
-8,804
-88% -$163K
FMBH icon
3735
First Mid Bancshares
FMBH
$1.38B
$21K ﹤0.01%
585
+6
+1% +$222
FSBC icon
3736
Five Star Bancorp
FSBC
$1.16B
$21K ﹤0.01%
805
+335
+71% +$8.87K
HIFS icon
3737
Hingham Institution for Saving
HIFS
$689M
$21K ﹤0.01%
73
-521
-88% -$164K
HLIT icon
3738
Harmonic Inc
HLIT
$1.3B
$21K ﹤0.01%
2,469
+700
+40% +$6.3K
STRR
3739
Star Equity Holdings
STRR
$40.1M
$21K ﹤0.01%
663
+654
+7,267% +$23.2K
HUMA icon
3740
Humacyte
HUMA
$148M
$21K ﹤0.01%
6,695
+2,516
+60% +$14K
IDT icon
3741
IDT Corp
IDT
$1.63B
$21K ﹤0.01%
835
-3,972
-83% -$110K
IMAX icon
3742
IMAX
IMAX
$2.81B
$21K ﹤0.01%
1,231
-462
-27% -$7.51K
IRIX icon
3743
IRIDEX
IRIX
$14.3M
$21K ﹤0.01%
8,212
+3,562
+77% +$12.1K
KALV
3744
DELISTED
KalVista Pharmaceuticals
KALV
$21K ﹤0.01%
2,119
-69
-3% -$761
TBHC
3745
DELISTED
The Brand House Collective
TBHC
$21K ﹤0.01%
5,902
+3,492
+145% +$22.3K
LPTH icon
3746
Lightpath Technologies
LPTH
$824M
$21K ﹤0.01%
17,167
-268
-2% -$420
MRC
3747
DELISTED
MRC Global
MRC
$21K ﹤0.01%
2,136
-12,517
-85% -$139K
MTLS
3748
Materialise
MTLS
$393M
$21K ﹤0.01%
1,565
+806
+106% +$12.7K
OSPN icon
3749
OneSpan
OSPN
$609M
$21K ﹤0.01%
1,800
+1,250
+227% +$16.5K
PAM icon
3750
Pampa Energía
PAM
$4.26B
$21K ﹤0.01%
1,037
+737
+246% +$16.3K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.